Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Genenta Science S.p.A. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
GNTA
Nasdaq
2834
www.genenta.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Genenta Science S.p.A.
TOP ITALIAN AND U.S. LIFE SCIENCES EXECUTIVES AND ITALIAN GOVERNMENT LEADERS SHARED BUSINESS SUCCESS STORIES WITH INVESTORS AT "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE
- Jan 28th, 2025 1:01 pm
3 Penny Stocks In US With Market Caps Below $300M
- Jan 13th, 2025 12:10 am
Genenta Science announces amendment to pact with AGC Biologics
- Jan 10th, 2025 11:51 am
Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing
- Jan 9th, 2025 11:00 am
ITALIAN TRADE AGENCY TO HOST "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE
- Jan 8th, 2025 8:17 pm
3 US Penny Stocks With Market Caps Over $30M To Consider
- Nov 13th, 2024 5:05 pm
Genenta’s CEO to present at the U.S. Senate meeting on “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective”
- Oct 23rd, 2024 11:00 am
Genenta Science S.p.A.'s (NASDAQ:GNTA) market cap rose US$46m last week; individual investors who hold 55% profited and so did insiders
- Oct 11th, 2024 11:35 am
Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer
- Oct 2nd, 2024 10:30 am
Genenta Science S.p.A. (GNTA): Early Investment Opportunity in Innovative Biotech
- Sep 30th, 2024 9:12 am
7 Penny Biotech Stocks to Triple Your Investment
- May 28th, 2024 10:10 am
Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider
- May 6th, 2024 10:25 am
Genenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid Tumors
- Feb 8th, 2024 10:00 am
Scroll